Decision by the Danish Medicines Agency – letters sent to companies
12 July 2010
On 11 June 2010, the Danish Medicines Agency decided on the future reimbursement status of medicinal products for the treatment of cardiovascular diseases in ATC groups C09C, C09D and C09X (angiotensin II antagonists and renin inhibitors).
In the fact box to the right, you can find a link to the letter containing the decision which the Agency has sent to companies holding a marketing authorisation for medicinal products comprised by the decision.
Danish Medicines Agency, 14 June 2010